• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.30 -0.27 (-0.96%)
Streaming Delayed Price Updated: 11:59 AM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,149,992
Open 27.73
Bid (Size) 27.30 (5,100)
Ask (Size) 27.31 (3,900)
Prev. Close 27.57
Today's Range 27.30 - 27.77
52wk Range 20.91 - 27.94
Shares Outstanding 5,606,688,356
Dividend Yield 6.30%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Could Buying Eli Lilly Today Set You Up for Life? ↗
March 26, 2026
Eli Lilly is leading the GLP-1 market, and investors are enthralled with the stock. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
March 26, 2026
CAMBRIDGE, MA — March 26, 2026 — Shares of Sarepta Therapeutics (NASDAQ:SRPT) skyrocketed 34.98% in heavy trading today, marking the biotech giant's most explosive single-day gain in over two years.... 
Via MarketMinute

Performance

YTD
+8.4%
+8.4%
1 Month
+0.6%
+0.6%
3 Month
+8.8%
+8.8%
6 Month
+15.7%
+15.7%
1 Year
+8.3%
+8.3%

More News

Read More
News headline image
Is Pfizer Stock a Buy After This Win? ↗
March 25, 2026
Via The Motley Fool
Pfizer Inc. (NYSE:PFE) Shows Strong Technical Setup for Potential Breakout ↗
March 20, 2026
Via Chartmill
News headline image
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
March 25, 2026
Via Finterra
Topics Initial Public Offering Intellectual Property World Trade
News headline image
Sarepta Therapeutics (SRPT) at a Crossroads: A 2026 Deep Dive into the Future of Genetic Medicine
March 25, 2026
Via Finterra
Topics Economy Intellectual Property Retirement
News headline image
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
March 25, 2026
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
Stay informed about the most active stocks in the S&P500 index on Tuesday's session. ↗
March 24, 2026
Via Chartmill
News headline image
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
March 24, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
March 24, 2026
Via Benzinga
News headline image
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
March 23, 2026
Via MarketMinute
Topics Economy Initial Public Offering Intellectual Property
News headline image
Pfizer Stock Is Doing Something It Hasn't Done Since 2022 ↗
March 23, 2026
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
5 High-Yield Stocks to Shield Your Portfolio From the Storm ↗
March 23, 2026
Via MarketBeat
News headline image
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive ↗
March 23, 2026
Via Benzinga
News headline image
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
March 23, 2026
Via Benzinga
Topics Stocks
News headline image
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
March 23, 2026
From Pfizer Inc.
Via Business Wire
News headline image
Have $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now ↗
March 23, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Unpopular Stocks That Should Get More Attention and 1 We Avoid
March 23, 2026
Via StockStory
Topics Supply Chain
News headline image
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
March 20, 2026
From Pfizer Inc.
Via Business Wire
News headline image
My Top 3 Drug Stocks for March 2026 ↗
March 20, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗
March 19, 2026
Via The Motley Fool
Topics Intellectual Property
Which S&P500 stocks are the most active on Thursday? ↗
March 19, 2026
Via Chartmill
News headline image
Follow the Footprints: 3 Stocks with Unusual Options Activity That You Can’t Ignore
March 19, 2026
Via Barchart.com
Topics Economy Stocks
News headline image
Is It Too Late to Buy Eli Lilly? ↗
March 19, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Looking for Safety and Yield as Oil Prices Whip Saw? This Stock Has You Covered.
March 19, 2026
Via Barchart.com
Topics Earnings

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 27.30
When was Pfizer last traded?
The last trade of Pfizer was at 03/27/26 11:59 AM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 153.09B
How many shares of Pfizer are outstanding?
Pfizer has 153B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap